Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-04-01
DOI
https://doi.org/10.1136/bmjopen-2024-093920
Citations
4
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
5.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial

Vesna Brglez, Sylvain Bénito, Barbara Seitz‐Polski, Marion Crémoni et al.
4 citations
BMJ Open
Renal Diseases and Glomerulopathies
5.72
article

Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial

Vesna Brglez, Sylvain Bénito, Barbara Seitz‐Polski, Marion Crémoni, Alexandre Destère, Maxime Teisseyre, Kévin Zorzi, Laurent Bailly, Céline Fernandez
article en
4 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(4)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Centre Hospitalier Universitaire de Nice (FR), Laboratoire Jean-Alexandre Dieudonné (FR), Institut de Recherche sur le Cancer et le Vieillissement de Nice (FR), Bases, Corpus, Langage (FR)
Ministère de la Santé
Good health and well-being
Openalex Percentile: Top 4%
Renal Diseases and Glomerulopathies
5.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.